Vol. 3, No. 6 — June 2026Independent since 2024

TheCompound Journal

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.

The Supply Chain Dispatch

Holograms, QR codes and other things that are not verification

Reported from the analysis, not from a warning notice.

The health authority in Denmark has issued a warning on falsified tirzepatide injection pens found in the legitimate supply chain. The Journal has reviewed the notice and the accompanying photographs; the distinguishing features are a batch-number font difference and a needle-shield colour, neither of which a patient could reasonably be expected to detect.

Comparison of 13 certificates supplied by the reseller against the laboratory’s public archive matched 6 of them to reports commissioned by other parties, in some cases more than a year earlier. The reseller did not respond to two written requests for comment.

The document is the weakest link in this trade. A certificate is a PDF; a laboratory letterhead is an image; a lot number is a string. Nothing in the ordinary transaction allows a buyer to confirm that a given report was issued for a given vial, and the four independent services differ in whether they offer any lookup at all.

Alastair Renshaw, pharmaceutical supply-chain consultant, said the underfill finding was the more consequential one. "Nobody is being poisoned by a low content figure. Everybody using that vial is out by a fifth in every calculation they make."

Readers holding a certificate they cannot verify can send it to the standards desk. We compare against archives where they exist and publish the aggregate.

Related coverage